Aprof Nicholas Gough
Pharmaceutical
Cancer Therapeutics CRC
Australia
Biography
Over 35 years experience in the biotechnology industry, and in the Cooperative Research Centres program, Dr Gough is the inventor of technologies underpinning a number of biopharmaceuticals and biotechnology products, including GM-CSF (sargramostim), one of the first pharmaceuticals based on Australian science and IP, mavrilimumab, under development by AstraZeneca for rheumatoid arthritis, and ESGRO™ used for the maintenance of embryonic stem cells.
Research Interest
Arthritis
